lenalidomide
PolandDrugs containing this active substance
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd. STADA Arzneimittel AG
-
The medicinal product is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd. STADA Arzneimittel AG
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd. STADA Arzneimittel AG
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd. STADA Arzneimittel AG
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd. STADA Arzneimittel AG
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica, S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica, S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica, S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica, S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is intended for adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicinal product is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: AS Grindeks
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is intended for adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.